HOME >> MEDICINE >> NEWS
Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years

ffect the nose, but patients also report itchy, watery eyes, sneezing and nasal congestion. SAR often remains undiagnosed and untreated because people mistake their symptoms as related to a "cold" or the "flu."

What Is Chronic Idiopathic Urticaria (CIU)?
Chronic idiopathic urticaria (CIU), is caused by a reaction to an unknown trigger in the upper layers of the skin. Its primary symptom is the formation of itchy hives that last less than 24 hours but can recur frequently for six weeks or longer. The cause of CIU cannot be discovered in at least 75% of cases.


'"/>

Contact: Charles F. Rouse III
973-394-6050
Porter Novelli
4-Jun-2000


Page: 1 2 3

Related medicine news :

1. Aventis Pasteur ready to meet nations needs for tetanus and diphtheria vaccine
2. Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
3. Aventis Pasteur statement on HVTN 501 decision
4. Millennium, Aventis Pharma form novel alliance
5. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
6. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
7. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
8. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
9. Pharmaceuticals and personal care products
10. Nortran Pharmaceuticals Inc. and Hoechst Marion Roussel announce collaborativeagreement
11. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... 20, 2017 , ... EdChoice and the American Enterprise Institute ... promote economic development in economically distressed urban areas. The first report presents a ... to the economic development of the city of Santa Ana, California. The second ...
(Date:6/20/2017)... Ohio (PRWEB) , ... June 20, 2017 , ... ... gum disease in Cincinnati, OH for leading-edge care, whether or not ... in laser dentistry. Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and ...
(Date:6/20/2017)... ... June 20, 2017 , ... Many RNA binding proteins ... the research team developed expressRNA, a web platform encompassing computational tools for integration ... nucleotide resolution the ‘RNA maps’, which demonstrate that RBPs bind to specific positions ...
(Date:6/20/2017)... ... 20, 2017 , ... John D'Eri, CEO of Rising Tide Car Wash ... Award during the Autism Society of America 's 49th annual conference to ... Fiddle Foundation (DJFF) was founded in 2002 as the nation's first autism organization ...
(Date:6/20/2017)... ... June 20, 2017 , ... Bellus Medical, a leader ... Vice President of Sales, a critical role to help spearhead business development, strategic ... , Mr. McKenna is a seasoned business leader, joining Bellus Medical with more ...
Breaking Medicine News(10 mins):
(Date:5/29/2017)... 2017  Cellect Biotechnology Ltd. (NASDAQ: APOP ... the functional selection of stem cells, today provided a ... quarter ended March 31 st , 2017. ... the first quarter of 2017," said Dr. Shai Yarkoni, ... the treatment of the first blood cancer patient in ...
(Date:5/26/2017)... May 25, 2017  In response to the opioid ... Direct Relief is working with Pfizer to make up ... no cost to community health centers, free and charitable ... "Pfizer has a long-standing commitment to ... ensuring patient safety through educational activities," said Caroline ...
(Date:5/23/2017)... May 23, 2017  Leaf Healthcare, recognized for ... devices for pressure ulcer prevention, will unveil its ... of Critical Care Nurses, National Teaching Institute and ... The Leaf Patient Monitoring System is the ... hospital environment.  The system seamlessly tracks patient movement ...
Breaking Medicine Technology:
Cached News: